HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Update on vaccination of cattle and wildlife populations against tuberculosis.

Abstract
In this review, the status of vaccination strategies to reduce bovine tuberculosis of cattle and wildlife reservoirs of the disease is discussed, with a focus on recent developments. Recent work in vaccines to protect humans against tuberculosis has been followed by a similar surge of interest in developing vaccines against bovine tuberculosis. The human vaccine, bacille Calmette-Guérin (BCG) affords protection against tuberculosis in cattle, but this protection is variable. In addition, vaccination with BCG compromises control strategies based on skin testing animals. In general, no single vaccine approach has shown itself to be significantly superior to BCG alone, however, vaccine combinations of BCG and vaccinating moiety such as adjuvanted subunit, virus vectored or DNA vaccines have been shown to induce protection superior to that achieved by BCG alone. Vaccinating wildlife species against tuberculosis is also an area which has been subjected to scrutiny. Recent work has focused on vaccinating wildlife orally, via the use of BCG formulated in baits consumed by these species. Results from trials in a number of animal species indicate that oral BCG vaccination can reduce disease severity following experimental challenge with Mycobacterium bovis and in a recent field trial, oral BCG vaccination was shown to prevent infection of wild possums following natural exposure to M. bovis. In conclusion, recent studies in cattle and wildlife have demonstrated the practicality and effectiveness of vaccinating animals against tuberculosis and provide much impetus for future use of vaccines.
AuthorsBryce M Buddle, D Neil Wedlock, Michel Denis, H Martin Vordermeier, R Glyn Hewinson (Affiliation: AgResearch, Hopkirk Research Institute, Palmerston North, New Zealand. bryce.buddle at agresearch.co.nz)
JournalVeterinary microbiology (Vet Microbiol) Vol. 151 Issue 1-2 Pg. 14-22 (Jul 5 2011) ISSN: 1873-2542 [Electronic] Netherlands
PMID21420804 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • BCG Vaccine
  • Vaccines, Attenuated
  • Vaccines, DNA
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Administration, Oral
  • Animals
  • Animals, Wild (immunology)
  • BCG Vaccine (administration & dosage, immunology)
  • Cattle (microbiology)
  • Mycobacterium bovis (immunology)
  • Tuberculosis, Bovine (immunology, prevention & control)
  • Vaccination (trends, veterinary)
  • Vaccines, Attenuated (administration & dosage, immunology)
  • Vaccines, DNA (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD